← Leaderboards
Adam Lerner
Boston Medical Center
$6,242,743
Attributed
$7,282,889
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $902.3K · FY2005–18$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$7,282,889 · 9
By mechanism
T32$4,064,607 · 1
R01$3,155,492 · 3
P41$62,790 · 5
Top collaborators
- Martin H. Steinberg5 shared
Most similar at Boston Medical Center
Same institution · by research overlap
- Neil B Ruderman$15,877,734
- Douglas T. Golenbock$31,091,869
- Zhijun Luo$3,331,949
- Richard A Cohen$17,708,073
- Wen Guo$3,443,492
Others in their field
Top investigators on “Hematological Disease”
- Ronald T Mitsuyasu · University Of California Los Angeles$116,828,445
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Stanley Carlton Ahalt · Univ Of North Carolina Chapel Hill$78,409,067
- Paul M. Ridker · Brigham And Women'S Hospital$55,416,022
- Mary M Horowitz · Medical College Of Wisconsin$47,632,939
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
Research focus
Hematological DiseaseResearch TrainingResourcesFamily MemberResistanceProteinsAdapter ProteinSrc-Family KinasesPhosphorylationMediatingFocal AdhesionsCancer Cell LineCellsEstrogen AntagonistsSignal TransductionBreast Cancer CellPlayCyclic AmpChronic Lymphocytic LeukemiaApoptosisBlood ResourceGrantBcar3 GenePrincipal Investigator
Grant awards (30)
Research Training in Blood Diseases and Resources$366,360
T32 · FY2018 · HL
Research Training in Blood Diseases and Resources$490,089
T32 · FY2017 · HL
Research Training in Blood Diseases and Resources$502,953
T32 · FY2016 · HL
Research Training in Blood Diseases and Resources$498,581
T32 · FY2015 · HL
Research Training in Blood Diseases and Resources$222,310
T32 · FY2014 · HL
Research Training in Blood Diseases and Resources$314,738
T32 · FY2012 · HL · contact PI
Research Training in Blood Diseases and Resources$340,976
T32 · FY2011 · HL · contact PI
EFFECT OF PHOSPHORYLATION ON INTERACTION OF P130CAS WITH AND-34$15,376
P41 · FY2011 · RR · contact PI
Research Training in Blood Diseases and Resources$235,118
T32 · FY2010 · HL · contact PI
EFFECT OF PHOSPHORYLATION ON INTERACTION OF P130CAS WITH AND-34$20,903
P41 · FY2010 · RR · contact PI
Research Training in Blood Diseases and Resources$432,915
T32 · FY2009 · HL · contact PI
Cyclic AMP-mediated apoptosis in lymphoid malignancies$241,199
R01 · FY2009 · CA · contact PI
EFFECT OF PHOSPHORYLATION ON INTERACTION OF P130CAS WITH AND-34$21,328
P41 · FY2009 · RR · contact PI
Research Training in Blood Diseases and Resources$429,389
T32 · FY2008 · HL · contact PI
Cyclic AMP-mediated apoptosis in lymphoid malignancies$241,199
R01 · FY2008 · CA · contact PI
Analysis of AND-34 in human breast cancer$229,749
R01 · FY2008 · CA · contact PI
EFFECT OF PHOSPHORYLATION ON INTERACTION OF P130CAS WITH AND-34$1,951
P41 · FY2008 · RR · contact PI
Cyclic AMP-mediated apoptosis in lymphoid malignancies$241,199
R01 · FY2007 · CA · contact PI
Research Training in Blood Diseases and Resources$231,177
T32 · FY2007 · HL · contact PI
Analysis of AND-34 in human breast cancer$229,749
R01 · FY2007 · CA · contact PI
EFFECT OF PHOSPHORYLATION ON INTERACTION OF P130CAS WITH AND-34$3,232
P41 · FY2007 · RR · contact PI
Cyclic AMP-mediated apoptosis in lymphoid malignancies$248,402
R01 · FY2006 · CA · contact PI
Analysis of AND-34 in human breast cancer$236,611
R01 · FY2006 · CA · contact PI
Research Training in Blood Diseases and Resources$1
T32 · FY2006 · HL · contact PI
Cyclic AMP-mediated apoptosis in lymphoid malignancies$254,380
R01 · FY2005 · CA
Analysis of AND-34 in human breast cancer$242,305
R01 · FY2005 · CA
APOPTOSIS IN NORMAL AND MALIGNANT LYMPHOCYTES$248,063
R01 · FY2003 · CA
APOPTOSIS IN NORMAL AND MALIGNANT LYMPHOCYTES$248,063
R01 · FY2002 · CA
APOPTOSIS IN NORMAL AND MALIGNANT LYMPHOCYTES$248,063
R01 · FY2001 · CA
APOPTOSIS IN NORMAL AND MALIGNANT LYMPHOCYTES$246,510
R01 · FY2000 · CA